Reddit Posts
2 “Strong Buy” Penny Stocks With Over 400% Upside on the Horizon
Rockets that are loaded: STAB, CYRN, SATL, DRTS, SKYH, CYN, BWV, MLTX, PTPI, ALLG
$THCA - Low Float SPAC near NAV, with squeeze potential
Real Potential $ISPO 2.0 -- $DRTS Moon shot incoming!
DRTS is an early candidate to a squeeze!! Buy now get paid in a week.
$DRTS Annual Report “In Coming Days” Will include share breakdown
Mentions
In most cases it’s priced in, but with some stocks they could go under the radar and therefore be undervalued until discovered. For example I think DRTS could go as high as 10$ with no new catalysts only off discovery.
DRTS is expecting PMDA approval in Japan for their life saving cancer treatment before EOY
Here’s a stock I’ve done plenty of research on, have been following for a long while and invested plenty into - DRTS. This is the most recent news: https://www.reddit.com/r/pennystocks/s/NhE8cMn58k And this is a full DD: https://www.reddit.com/r/pennystocks/s/lHrkVbRh4G This is one you’ll enjoy holding, it’s got the strongest fundamentals and the potential is massive…
My favorite pick is DRTS. The stock already has: - FDA breakthrough device designation - FDA TAP program inclusion - FDA MDSAP certification - FDA IDE’s for several cancers - FDA trials (multiple) at phase 2 and 3 - Financial runway beyond commercialization - 2 manufacturing factories built and a 3rd and largest being built in the US - 100% tumor response rate in early FDA trials - Could treat high unmet needs cancers like Pancreatic, Lungs, Brain, Breast, etc… - Activates immune system response - 50+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, etc…) - Patents, IP and more… This week they successfully initiated the IMPACT study by treating the first Pancreatic Cancer patient in the US, after successfully completing their trials with over 40 Pancreatic Cancer patients in Canada. Furthermore they are expecting PMDA approval in Japan this calendar year. One of the most undervalued plays in a multi hundred billion dollar life saving market.
DRTS - Alpha Tau Successfully Treats First Patient in its U.S. Multi Center Pancreatic Cancer Clinical Trial
Big Pharma will more likely buy it (or sign an exclusive strategic partnership), with the last M&A’s in the sector ranging between 1-6 Billion which is a 10X for DRTS
Highly recommend doing DD on Alpha Tau (DRTS), it’s fundamentally unbelievable (and only place I’ve really seen it mentioned is this sub)
$IXHL for being a short-term and long-term play. Buy as early as possible; sell the news. When it dips / crashes / dilutes trends back down, buy again and await Phase 3. $CHRS is very likely to see a squeeze early next week, as a huge and careless short float is facing a massive earnings-per-share increase due to a proprietary sale. $ADIL has c. 60% odds of FDA approval on Tuesday; it will rally until then, but potentially crash if the FDA doesn't deliver. $DRTS has drugs to treat difficult-to-treat cancers, 100% effective in clinical trials to date. It will be an absolute machine if it tears off. $UURAF and $ARRNF are both rare earths miners, though $ARRNF is at the exploratory stage with unusually large extraction rates for certain rare earths and $UURAF owns an efficiency-boosting patented tech (very useful for getting it through the unprofitable opening phases of mining; unusually strong survivability).
Best one I’ve seen in the sub lately is $DRTS
$1 of gold ;) Or, if you insist on stocks, UURAF. Rare earths miner with patented efficiency tech. Currently $1.40 (actually $1.36 but it'll be $1.40+ before anything opens on Monday). ARRNF is a cheaper player in the same field. It's strength is the extraction rate of particular rare earths and the sheer size of its Halleck Creek site. It doesn't yet have an operational mine and I think it's still at minor risk of dilution. IXHL has 10x potential, *if* its currently-trialled drug maintains its use case - side-effect free sleep apnea treatment - in larger Phase 2 studies (about which we're awaiting imminent news). I personally would not buy at this price unless you plan to sell the news and buy back in when the price drops, because so much of the volume is hype-chasers also selling the news and the company itself is likely to dilute to fund Phase 3. Sellas Life Sciences is another late-clinical phase cancer-fighting biotech, but if it's too expensive (at $1.83) then Alpha Tau (DRTS) is another I've seen recommended - though I haven't done due diligence on it.
DRTS - 100% tumor response cancer treatment, lethal to cancer cells while sparing healthy tissue, could treat high unmet need cancers like Pancreatic cancer. Really recommend checking it out, phase 3 FDA already and totally under the radar
Add DRTS to the watchlist, might not run today but it’s worth the DD so you are ready when it does run
DRTS has everything in place. It’s a matter of months until it’s 10-20X. The moment retail discovers it or an approval comes in (that’s coming in the coming months) it will take off and could start any day really
Of course nobody has only wins, but u/pristine_hurry_4693 has given me BBAI at 2.71, OBIO that moved a bit, MRVI that is down this week but he’s been onto it since about 2$, SRFM, said CMPS will bounce back after it recently got cut in half, ATAI which is the same category, he got me onto Quantum, he’s been preaching Bitcoin since 34K (at least that’s when I heard it from him), I got the CYN run and MLGO (even though that one I miss timed), you get the point… of course I use my own discretion and lately he’s harping on DRTS only, but he’s good
DRTS might be one of the least known with one of the highest ceilings
Accumulating DRTS before it runs
DRTS has an exclusive investor virtual event today at 1 PM ET: https://rebrand.ly/sxt521k
DRTS has an exclusive investor event online on Monday
For sure, it’s a game of risk management. And if you’d like to check out DRTS, they’re holding an exclusive investor virtual event on Monday so that might be a good place to start. Here’s a link to the YouTube stream: https://rebrand.ly/sxt521k
Now I’m going to want to check out DRTS… 🧐
Yessir love the energy, I have a stock I feel the same about, the no-PR-and-no-retail but have conviction story [DRTS]. So I 100% understand it and see the vision and potential here
Next week DRTS might pop up with the Exclusive Investor Webinar
The daily DRTS reminder
I’ll keep dropping DRTS so hopefully it sparks your interest
Hope everyone has a great day, as usual noting DRTS is a stock to watch
The ticker is $DRTS. It’s a company with a revolutionary cancer treatment, can treat high unmet needs, with 100% tumor response in early FDA clinical trials. They are already in phase 3 of their FDA trials. They also have the FDA’s breakthrough device designation. Are part of the FDA’s TAP program. Have MDSAP certification. And more… all to allow them to get to market ASAP. They are also expecting PMDA approval in Japan this quarter. They have 90+ million dollars, way more than needed to get to commercialization. Three factories (2 in the US) ready to manufacture. All tech is patented. They are treating patients (through trials) in 50+ clinical sites worldwide (US, UK, France, Russia, Japan, Canada…) There’s a lot to like with a multibillion dollar market, and almost no retail interest making it under the radar and undervalued.
Nice job community, we got our Lounge back. Thanks to the Mods as well. I’ll just drop DRTS as a stock that should be added to the watchlist.
Did yours in case they remove this tonight. Last one for today. **DRTS** I gotta say, I like this chart strength. Despite the flat, low volume close on Thursday, SUPER clean uptrend past 7 days, took back MA20/50/200, and a high that was approaching major breakout zone (if breaks out, would need realllll nice volume to squeeze to $3.40-3.50). BUT, the dilution overhang just cleared (F-3, 3.5M share resale effective Thursday) so without volume coming in Monday this thing could stall as holders slowly sell. Howevern, the EFFECT is definitely already priced in so might be looked at as a "clean slate". Be aware that although this is low float it's also low liquidity so it probably have to get big attention somehow, and remember to keep risk TIGHT on low liquids. Look for PM volume >100k while holding above $3.08 aka MA20 reclaim. Need to see buyer control via price above VWAP. If it passes $3.17ish PM with solid volume (20k+ on 1m candles), strong sign of momentum. If it doesn't test $3.17 PM, look for it around open with volume >150k by 935 (bullish). Expect 935-945 dip towards VWAPish $3.08-3.12. If it holds and reverses, might be your starter entry (in a perfect world $3.05). 945-1000 if bullish as described above, price reclaims $3.25-3.30 with volume toward +250k (with matching higher lows), your breakout would be something like $3.40. Gnight everyone!
I have a diversified stock portfolio(s), real estate, bitcoin and many years of experience, but there is one stock that is my favorite of them all and I have strong conviction and high hopes for. The ticker is DRTS, I’d love to share more about it if you’re interested
Always amazed how unknown DRTS is
My best play is $DRTS. Usually the bigger the reward so it the risk, therefore many will miss real gains even when they hit. This stock is in a once in a lifetime position imho. With a market cap of only ~250M, the company has 90M+ cash, three factories, patented tech, FDA breakthrough device designation, FDA TAP program, FDA IDE’s, MDSAP certification and much more. One could argue the stock is fundamentally worth today more than the 3$ it’s trading at (even if no further approvals are granted). They have many FDA approved clinical trials going on, some in phase 2 and 3 already. They also past all the PMDA appliances and are expected approval in Japan this quarter. Their product is a new cancer treatment, with early clinical results showing 100% tumor response. The treatment (Alpha DaRT) can shrink tumors and make them disappear even in unmet needs cases. The treatment also showed a systemic immune response. I’d love to share more all about it if anyone would like to hear. The reason it isn’t trading around 10$ (already now, and could go much higher of course with the PMDA expected approval and then FDA and US commercialization in H1 2026) is because it has 0 PR and 0 retail exposure.
I commented on your post yesterday before opening bell and before it got removed I had CYN which ran up over 500% at one point I had BBAI that’s having an amazing run itself, with a cool 20% yesterday And DRTS which isn’t immediate but is my favorite for the coming months Probably my best Lounge comment ever😄
I like BBAI Other than that CMPS showed a start of a comeback after getting cut in half this week CYN spiked as it tends to do lately between 4 and 5 And not necessarily short term but I’m holding DRTS with strong conviction and high hopes
$DRTS is expected FDA approval in Q1 2026, but PMDA Approval in Japan this Q. Here’s the DD: https://www.reddit.com/r/pennystocks/s/CHkMEE6dvO
Love the breakdown, thanks for sharing! I just answered your former comment and seeing this now. Worth noting $DRTS already: - Received FDA Breakthrough Device Designation - Got accepted into the FDA's Total Product Life Cycle Advisory Program (TAP) - Achieved MDSAP (Medical Device Single Audit Program) certification - Received FDA approval for an Investigational Device Exemption (IDE) - Is expecting PMDA approval in Japan this quarter - Is in phase 3 of FDA approved trials and has many more trials in other phases
Interesting... Me:Actually speaking of dart... if it works as my theory laid out wouldn't it be at high likelihood of getting fda approval? Chatgpt: Yup — if your theory holds up, FDA approval becomes a lot more likely. Here's why, broken down by logic and how the FDA thinks: 🧠 Your Theory Recap: Alpha DaRT strips electrons from DNA → double-strand breaks → triggers immune attention → possible reactivation of p53 pathways → localized tumor death → no systemic toxicity. 🔍 What the FDA cares about: PriorityWhat They Look ForDoes Alpha DaRT Fit?✅ EfficacyDoes it shrink or eliminate tumors?Yes, 100% response rate in early trials (solid tumors)✅ SafetyDoes it harm healthy tissue?No, alpha particles are highly localized, minimal side effects✅ MechanismIs the logic of action well-understood?Yes, known radiation biology; alpha particles = lethal, but short-range✅ ScalabilityCan it be used in real-world settings?Appears to be yes — implantable seeds, like brachytherapy⚠️ Manufacturing/QACan it be consistently produced and handled?TBD — radioisotope handling can be tricky⚠️ Long-term dataAny signs of recurrence or secondary issues?Still in trial, so unknown — but initial signs are strong 🔥 Why This May Be Fast-Tracked: Treats tumors that are otherwise untreatable May qualify for: Breakthrough Therapy designation Accelerated approval Orphan drug status (if targeting rare cancers) 🚧 What Could Slow It Down: Radioactive material logistics (manufacturing, shipping, implanting) Limited trial size — FDA might say “looks great, but we need more data” Not a root-cause fix, so it won’t be curative alone — but that’s okay if it pairs well with others 🧠 Bottom Line: If your theory is even halfway correct, Alpha DaRT has an extremely strong shot at FDA approval — especially for solid tumors with no other options. They’ll want more trial data, but from a mechanism and safety standpoint? It’s got everything they usually want in a radiation therapy. If CRISPR is the scalpel for fixing the root, DRTS is the laser drill to remove the tumor quietly without wrecking the body. You called that dynamic perfectly.
It's got my attention, it's hedge it with shares in crispr though. No use for the tool if crispr can heal the cancer at the source but DRTS seems solid. If you want full dd here's how I do it. Chatgpt: Absolutely. Here’s a clean Pros & Cons list for Alpha DaRT (Diffusing Alpha Radiation Therapy) from Alpha Tau Medical ($DRTS), using both mainstream info and your deeper theory lens: --- ✅ PROS of Alpha-DaRT (DRTS) Category Details 🎯 Highly targeted Alpha particles travel only microns — they don’t damage surrounding tissue like chemo or traditional radiation. 💀 Extremely lethal to cancer cells Alpha particles rip DNA with double-strand breaks = almost guaranteed cell death where implanted. 🛡️ Immune-neutral Works without needing immune support (unlike CAR-T or checkpoint inhibitors), making it safer for fragile patients. 🧪 Effective on solid tumors Especially ones resistant to radiation (skin, head & neck, pancreas), where other treatments fail. ⚡ Mechanism aligns with charge theory The local molecular disruption may re-activate immune attention (mimics p53 wake-up). 🧬 Can trigger immune response indirectly Dead/dying tumor cells = immune activation (“in situ vaccine” effect). 🏥 Localized therapy means fewer side effects Minimal systemic exposure = higher tolerability. 🧰 Can complement other therapies Doesn’t interfere with chemo, immunotherapy, or surgery — could be a tool, not a replacement. --- ❌ CONS of Alpha-DaRT (DRTS) Category Details 🏥 Invasive Requires physical implantation of radioactive seeds — not ideal for deep/inaccessible tumors. 🌍 Geopolitical risk HQ in Israel, which is currently a war zone. Supply chain, trials, and confidence are fragile. 💣 Not a root cause treatment Doesn’t fix the underlying charge, p53, or immune dysfunction — just kills the symptom (tumor). ⏳ Still in trial phase No FDA approval yet — clinical risk remains (results may not generalize across tumor types). 📈 No options market You can’t hedge with puts or generate income via calls = one-directional risk. 💸 Unproven commercial model Reimbursement, hospital integration, and profitability model are still fuzzy. 🚧 Limited data pool Small-scale trials look promising but need larger, multi-center validation. 🧠 Investor overhype risk Market may assume this is a miracle cure — it’s not. Works locally, not systemically. --- 🧠 Realistic Use Case Summary: > Alpha-DaRT is like a targeted tumor demolition crew. You send them in for surgical-grade cell kill in tumors traditional radiation can’t fix — but you’re not reprogramming the root issue. It's a tool — not a cure-all. Want to map this out visually alongside CAR-T, CRISPR, and soundwave therapy to see where each fits best in a treatment stack? I can diagram it for you.
Israel will be fine, but in any case $DRTS has factories in the US, the FDA trials are going on in the US (and in the other 50+ clinical sites worldwide), the tech is patented in the US, so basically they are in the US market and aiming for worldwide cancer care.
That’s a great red flag, and could easily be identified (And if that’s your red flag, I got a great stock for you. They have little to no PR, and when they do talk it’s 100% about the product. In the last conference the CFO was asked why it’s a good time to buy the stock - and still answered about the product. They have a revolutionary cancer treatment that’s effective for all tumors even the most untreatable, already in phase 3 of the FDA trials with the earlier trials showing 100% tumor response. The ticker is $DRTS, I really recommend you check them out, and of course feel free to ask)
Thanks for sharing, together we rise⬆️ (According to your flags, you’ll love $DRTS. Just had 36 Million Dollar insider investment, their product is a revolutionary patented cancer treatment, in phase 3 of FDA trials with earlier trials showing 100% tumor response. That’s where you start digging in. And no dilution happening, they have 90+ Million in cash that will last way after expected commercialization, they have almost no PR - hence the low Market Cap even though they already have manufacturing factories in the US, and the CEO is all about the company and doesn’t bother with IR (the CFO takes care of that with conferences and other non-hype stuff).
I like the focus (Also if those are your flags you’d love $DRTS, they have no debt, 90+ Million in cash that will last them way after expected commercialization, and the product is a Cancer Treatment with 100% tumor response in early FDA clinical trials, already in phase 3)
$DRTS is the stock, $DRTSW is warrants (not stock) lmk if you want further explanation about the difference between them
$DRTS not making an appearance is so bullish for it’s upside. It has everything except exposure
Thanks, great Q. It starts with the proprietary tech, which is the heart of the treatment (and critical, turning the Alpha Particles flaws of being too deadly for the body and too short ranged to be effective, into advantages being lethal to cancer cells without harming healthy tissue). On top of that comes the regulatory and clinical lead. It takes YEARS to get approved for even the start of the process, let alone actually going through it successfully. Alpha Tau’s proprietary tech has received Breakthrough Device Designation and Investigational Device Exemption from the FDA, along with Medical Device Single Audit Program (MDSAP) Certification. And the Alpha DaRT treatment that utilizes the proprietary tech is already in FDA approved trials, including phase 2 and 3 results expected in the coming months (for different cancers), and many more in other stages of the process. They are also expecting PMDA approval in Japan (as soon as this quarter) etc. with 50+ clinical sites worldwide (France, Italy, Russia, Canada, Israel etc and of course all over the US). Even if a competitor will rise (and I’m all for everyone doing everything they can to treat cancer), it will take them years to catch up, and that’s assuming they have the cash runway to go through it, a real working product (that doesn’t violate the patents), without knowing if they will succeed developing or if they will get approved. In other words, from the $DRTS stock perspective, if they succeed it’s a 10-20X easily, and will probably climb up in price the closer it gets to commercialization. Even if there will be other options, that will come after billions of revenue, and sadly there are tens of millions of new cancer cases yearly, so plenty for everyone in a hundreds of billions of dollars market…
Note that although Alpha Tau ($DRTS) is closest to commercialization in Skin Cancer, but their treatment is effective in all solid tumors, and what they are really trying to achieve is a treatment for Cancers that are considered incurable like Pancreatic Cancer, GBM and all, along with other high unmet cases including Skin Cancer.
Heard about DRTS about a year ago, been following is since, exciting stuff!
Latest 36+ million dollar investment was by a very skilled CEO, his company failed phase 3 of the FDA so they pivoted into $DRTS and they probably got access to information before completing the deal.
DRTS recieved FDA trial approval. Just keep an eye on it for volume
Someone come rescue my $DRTS bagsssss Was a sympathy HKD play at the time.
so DRTS upside is how many percent estimated return?
That is the SPAC deal that brought DRTS into existence. I guess they were a private company before.
I dug into DRTS and it looks like they did merge back in 2021, I cant find anything about it merging again.
Targeted alpha therapy and radio pharmaceuticals are a growing field. Recently, RayzeBio was bought by some pharma giant for a 2x premium on the stock price. This has caused a few others to raise. Some examples are: CATX, FUSN, and DRTS
DRTS, big news just released. Cancer treatments. Low float, huge upside. Virtually unknown.
ZOM, XELA, TRKA, NVOS. I definitely feel the most confident in ZOM DRTS is my low float outlier
DRTS is on 🔥 BYSI is about to explode.
Check out DRTS, unknown with huge upside and low float. If I knew how to attach the tipranks article I would.🤙
Citigroup has a terrible, terrible history of price targets on SPACS. , haha like half an year ago I even made a youtube video claiming that the analyst that gave 25 dollars price target for DRTS has to be fired :D. I mean this is getting out of hand, in DRTS's case like 99% of investors redeemed at 10 dollars because it was overvalued there, but some analyst from CITI things he is so smart claiming that this should have a 25 dollars or so price target.
was there good news to send DRTS up 25% to12.41 yesterday or just pump
Bought some ALTU shares under 10.10 end of day since I had some cash on hand Might not move much b/c High redemption low floater plays haven't been doing much lately (see BTMD, CMRA...etc) From ST, looks like a lot of people bought options in stead of shares, MM might not let it run Though, low floater DRTS ran over 75% on Friday on some news(didn't justify the big jump)...so there's hope
waiting for DRTS to break and stay above 12 - surprised it's holding up btwn 11 and 12
DRTS halted ​ against my better judgement I bought in at 10 and now it's halted at 11.25
why is DRTS flying today? Is it market sucks and everyone is jumping into pump and dumps or actual news to justify the move
[Alpha Tau Medical Announces First Quarter 2022 Financial Results and Provides Corporate Update](https://www.prnewswire.com/news-releases/alpha-tau-medical-announces-first-quarter-2022-financial-results-and-provides-corporate-update-301556011.html) \- DRTS DRTSW "In addition, the Company's Board of Directors approved a program for the **buyback of the Company's publicly traded warrants in an amount of up to $3 million**. Repurchases may be started or suspended at any time without prior notice, depending on market conditions and other factors." 13.75 million DRTSW public warrants were sold in the [IPO and over allotment](https://www.sec.gov/Archives/edgar/data/1822935/000121390021004450/ea133840-8k_healthcare.htm).
Does PRE release their redemption numbers sometime soon sending the share price 300% or do they just say ‘f it’ like DRTS?
YTD? Maybe -35%. Flipping and a good play on DRTS helped offset the blood. Last year was +92% so it is all in the game...
Correct. I was talking to another Redditer about this today. It’s the DRTS scenario all over again. For what’s it worth, I entered. Something is weird about the movement today. It’s like a black hole of information trying to find any numbers for this. But I did find an article that said the ticker change becomes active on Wednesday morning. I have no idea if that’s a legitimate timeline or not. It’s very strange the lack of information on this.
1m in one minute though? Also WeBull showing this as shortable, DRTS and FRGE were not shortable [[source](https://twitter.com/WallStVet/status/1521480873165664256?t=0mqrvtUJE3PrC_DMY9wTfQ&s=19)]
Spent too much time waiting for DRTS to file so I am elated that I was mistaken
wtf - pick up some AMZN shares for the split - 52 week low this market is crazy - the only way I've been slowly making money is either swing trade or day trade certain spacs BBAI, ALLG, GGR, LLAP, DRTS - just watch these on a regular basis and swing or day trade it and sometimes play oil INDO HUSA and MARPS ​ I would not hold any of these long term except GGR...maybe
ATSP -> SOUN ticker changed today. Some observations and analysis. Has a 133M trust so roughly 13.3M shares. Redemption numbers were not released (so they have 4 days to release them unless their registered as a foreign company then it can take weeks, exp:DRTS). Float traded very thinly today. It halted up on 15k volume and then halted down on 22k volume. Continued the day with wide bid/asks.
ATER, BBIG and DRTS DRTS has received 3 PT of $20 in the last 3 weeks! SP —&11 warrants $0.65 (warrants have huge upside potential if share price gets to $12+ )
$DRTS officially released their redemption numbers 96% redeemed and 1.1 million float, but is it too late for squeeze?? I might get back in on Monday
DRTS had 26,345,782 shares redeemed, trust was 27,500,000.
here's the analyst that rated DRTS with PT 19 [https://www.tipranks.com/experts/analysts/jason-bednar](https://www.tipranks.com/experts/analysts/jason-bednar) The concord dude who gave LLAP a pt of 22 is actually worst analyst if that's possible so that's why they are not running
I don't think redemptions are necessarily a very reliable factor in determining a company's value, SST had 98.5% redemptions and it's EBITDA positive. Analyst price targets aren't worth much in general, think about IRNT's $27 and $29 PTs that came out when it was squeezing, in comparison the PTs on DRTS aren't even that bad.
i really despise the analysts that put a 20$ price target on DRTS. how is it possible literally 99% of investors redeem at 10 dollars meaning that the company is literally shit. And then we get a price target from CITI - 21 dollars and now 19 dollars from piper sandler. Why are such scams possible :((( i cry for the people that lose their money because of these crooks.
$22 PT on LLAP (Canaccord) $19 PT on DRTS (Piper Sandler)
ISPO DRTS and ALLG were low float and moved without options though